$GRYP
Gryphon Digital Mining Inc Stock $gryp

$gryp Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022072131 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$13.65M	$5.413M	$5.136M
YoY Change	468.54%	5.4%	38.27%
Cost Of Revenue	$5.412M	$2.052M	$1.971M
YoY Change	94.72%	4.08%	13.3%
Gross Profit	$8.233M	$3.361M	$3.164M
YoY Change	113.89%	6.22%	60.28%
Gross Profit Margin	60.33%	62.09%	61.61%
Selling, General & Admin	$14.40M	$3.706M	$4.080M
YoY Change	154.4%	-9.16%	-10.68%
% of Gross Profit	174.89%	110.27%	128.94%
Research & Development	$4.691M	$1.374M	$1.566M
YoY Change	167.42%	-12.28%	-10.94%
% of Gross Profit	56.98%	40.89%	49.51%
Depreciation & Amortization	$1.740M	$2.119M	$1.238M
YoY Change	-18.31%	71.08%	5.76%
% of Gross Profit	21.13%	63.04%	39.14%
Operating Expenses	$24.71M	$4.199M	$6.885M
YoY Change	158.94%	-39.01%	-8.17%
Operating Profit	-$16.48M	-$838.0K	-$3.721M
YoY Change	189.38%	-77.48%	-32.64%
Interest Expense	-$3.675M	-$396.0K	-$238.3K
YoY Change	-1004.44%	66.2%	6362.79%
% of Operating Profit
Other Income/Expense, Net	-$221.1K	-$1.507M	$2.167M
YoY Change	-218.76%	-169.52%	41.01%
Pretax Income	-$59.34M	-$2.345M	-$1.553M
YoY Change	204.55%	50.94%	-61.03%
Income Tax	-$716.2K	-$40.67K
% Of Pretax Income
Net Earnings	-$80.01M	-$2.304M	-$1.553M
YoY Change	-20103.28%	48.32%	-60.96%
Net Earnings / Revenue	-586.39%	-42.57%	-30.25%
Basic Earnings Per Share		-$0.59
Diluted Earnings Per Share	-$27.32	-$0.59	-$58.75K
COMMON SHARES
Basic Shares Outstanding	4.430M shares	80.29M shares	25.93M shares
Diluted Shares Outstanding		3.884M shares	1.322M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$877.8K	$2.491M	$9.609M
YoY Change	-93.7%	-74.08%	-32.62%
Cash & Equivalents	$877.8K	$2.491M	$9.600M
Short-Term Investments
Other Short-Term Assets	$12.80M	$8.497M	$2.437M
YoY Change	436.49%	248.61%	23.1%
Inventory
Prepaid Expenses	$1.210M	$2.330M	$2.194M
Receivables	$674.6K	$1.371M	$1.648M
Other Receivables	$544.2K	$841.5K	$265.2K
Total Short-Term Assets	$14.89M	$13.20M	$13.96M
YoY Change	-18.31%	-5.44%	-26.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.88K	$124.8K	$52.32K
YoY Change	-68.08%	138.45%	-96.25%
Goodwill	$1.708M	$9.026M	$46.79M
YoY Change	-96.36%	-80.71%	0.62%
Intangibles	$2.165M
YoY Change	-89.98%
Long-Term Investments	$0.00	$226.1K	$226.1K
YoY Change	-100.0%	0.0%	-5.79%
Other Assets	$0.00
YoY Change	-100.0%
Total Long-Term Assets	$4.576M	$32.39M	$60.55M
YoY Change	-94.0%	-46.5%	-2.82%
TOTAL ASSETS
Total Short-Term Assets	$14.89M	$13.20M	$13.96M
Total Long-Term Assets	$4.576M	$32.39M	$60.55M
Total Assets	$19.47M	$45.59M	$74.51M
YoY Change	-79.39%	-38.81%	-8.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.510M	$1.271M	$1.809M
YoY Change	-22.29%	-29.75%	-69.85%
Accrued Expenses	$1.966M	$2.276M	$3.377M
YoY Change	-42.83%	-32.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$13.20M	$9.900M
YoY Change	0.0%
Total Short-Term Liabilities	$22.73M	$19.99M	$6.254M
YoY Change	-22.1%	219.65%	-65.51%
LONG-TERM LIABILITIES
Long-Term Debt	$1.407M	$4.575M	$3.834M
YoY Change	-65.72%	19.33%	-30.04%
Other Long-Term Liabilities	$161.8K	$499.2K
YoY Change	-72.23%
Total Long-Term Liabilities	$1.407M	$4.575M	$3.834M
YoY Change	-65.72%	19.33%	-30.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.73M	$19.99M	$6.254M
Total Long-Term Liabilities	$1.407M	$4.575M	$3.834M
Total Liabilities	$24.29M	$25.50M	$10.09M
YoY Change	-29.65%	152.74%	-57.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$167.6M	-$142.3M	-$71.30M
YoY Change	89.32%	99.63%	-35647962600.0%
Common Stock	$160.2M	$159.8M	$132.8M
YoY Change	9.71%	20.36%	59.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.826M	$20.09M	$64.42M
YoY Change
Total Liabilities & Shareholders Equity	$19.47M	$45.59M	$74.51M
YoY Change	-79.39%	-38.81%	-8.4%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$80.01M	-$2.304M	-$1.553M
YoY Change	-20103.28%	48.32%	-60.96%
Depreciation, Depletion And Amortization	$1.740M	$2.119M	$1.238M
YoY Change	-18.31%	71.08%	5.76%
Cash From Operating Activities	-$449.8K	-$3.263M	-$1.362M
YoY Change	-85.44%	139.55%	-67.42%
INVESTING ACTIVITIES
Capital Expenditures	$1.026M	-$1.587M	-$1.361M
YoY Change	-148.83%	16.57%	112.72%
Acquisitions
YoY Change
Other Investing Activities	$5.000K	$0.00	$0.00
YoY Change	-100.1%		-100.0%
Cash From Investing Activities	-$1.021M	-$1.587M	-$1.361M
YoY Change	-85.66%	16.57%	-76.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	141.1K	9.262M	559.7K
YoY Change	-99.03%	1554.73%	-4518.3%
NET CHANGE
Cash From Operating Activities	-449.8K	-3.263M	-1.362M
Cash From Investing Activities	-1.021M	-1.587M	-1.361M
Cash From Financing Activities	141.1K	9.262M	559.7K
Net Change In Cash	-1.329M	4.411M	-2.164M
YoY Change	-130.91%	-303.85%	-78.14%
FREE CASH FLOW
Cash From Operating Activities	-$449.8K	-$3.263M	-$1.362M
Capital Expenditures	$1.026M	-$1.587M	-$1.361M
Free Cash Flow	-$1.476M	-$1.677M	-$960.00
YoY Change	49.07%	174540.63%	-99.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-609746	usd
	dei	Trading Symbol TradingSymbol	KERN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	us-gaap	Plan Of Reorganization Dates Plan Is Effective PlanOfReorganizationDatesPlanIsEffective	2022-06-29
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001755953
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Registrant Name EntityRegistrantName	Akerna Corp.
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4023294	shares
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	100000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39096
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-2242651
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1550 Larimer Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#246
	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80202
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	932-6537
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4429847	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2490662	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13934265	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	7008261	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	508261	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1371133	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1403774	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2330032	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2383764	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	13200088	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	18230064	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	124760	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	153151	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	226101	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	226101	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6009163	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	7311676	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21609794	usd
CY2022Q3	us-gaap	Goodwill Goodwill	9025589	usd
CY2021Q4	us-gaap	Goodwill Goodwill	46942681	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9700	usd
CY2022Q3	us-gaap	Assets Assets	45591285	usd
CY2021Q4	us-gaap	Assets Assets	94483167	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4630681	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6063520	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3300000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6300000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2151235	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3543819	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	9900000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13200000	usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	9025	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	63178	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	19990941	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29170517	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	499206	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	582676	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4575000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4105000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	431453	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	675291	usd
CY2022Q3	us-gaap	Liabilities Liabilities	25496600	usd
CY2021Q4	us-gaap	Liabilities Liabilities	34533484	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4023294	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4023294	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	155	usd
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1550094	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1550094	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	402	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	159841800	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	146030203	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	356028	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	61523	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-142331164	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88508236	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	20094685	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	59949683	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45591285	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	94483167	usd
CY2022Q3	us-gaap	Revenues Revenues	5412802	usd
CY2021Q3	us-gaap	Revenues Revenues	5135502	usd
	us-gaap	Revenues Revenues	18449524	usd
	us-gaap	Revenues Revenues	14056414	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	2051862	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6091511	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5339929	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	3360940	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	3164120	usd
	us-gaap	Gross Profit GrossProfit	12358013	usd
	us-gaap	Gross Profit GrossProfit	8716485	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1374133	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1566478	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4517836	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1882980	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2002461	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8304411	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5564519	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1823076	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2077474	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6812617	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8306417	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2118739	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1238420	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6094963	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3605435	usd
CY2022Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	39600587	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022Q3	kern	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-3000000	usd
CY2021Q3	kern	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
	kern	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-3000000	usd
	kern	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4198928	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	6884833	usd
	us-gaap	Operating Expenses OperatingExpenses	63053500	usd
	us-gaap	Operating Expenses OperatingExpenses	21994207	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-837988	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3720713	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-50695487	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13277722	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-396022	usd
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-238283	usd
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	290000	usd
CY2021Q3	kern	Gains Losses On Convertible Notes GainsLossesOnConvertibleNotes	-23227	usd
	kern	Gains Losses On Convertible Notes GainsLossesOnConvertibleNotes	-2840000	usd
	kern	Gains Losses On Convertible Notes GainsLossesOnConvertibleNotes	-2030904	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2256	usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	194046	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	54153	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	151175	usd
CY2022Q3	kern	Gainon Ppp Loan Forgiveness GainonPPPLoanForgiveness		usd
CY2021Q3	kern	Gainon Ppp Loan Forgiveness GainonPPPLoanForgiveness	2234730	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1175789	usd
CY2022Q3	kern	Gains Losses On Convertible Notes GainsLossesOnConvertibleNotes	-1113000	usd
	kern	Gainon Ppp Loan Forgiveness GainonPPPLoanForgiveness		usd
	kern	Gainon Ppp Loan Forgiveness GainonPPPLoanForgiveness	2234730	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	243	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1506766	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2167266	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3395593	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-820545	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2344754	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1553447	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-54091080	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14098267	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-40666	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-268152	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10570	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7564	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-2304088	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1553447	usd
	us-gaap	Profit Loss ProfitLoss	-53822928	usd
	us-gaap	Profit Loss ProfitLoss	-14116401	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3883847	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1322122	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2421262	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1215626	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-22.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.61
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-2304088	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1553447	usd
	us-gaap	Profit Loss ProfitLoss	-53822928	usd
	us-gaap	Profit Loss ProfitLoss	-14116401	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	27676	usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	63905	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4505	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	65858	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	26000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	-3000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2250412	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	20094685	usd
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	-19000	usd
	kern	Fair Value Adjustment Of Contingent Consideration FairValueAdjustmentOfContingentConsideration	-3000000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1492542	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53528423	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14069543	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12945012	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	9178961	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	196124	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	25000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	27676	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	26000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-2304088	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	59949683	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3925500	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	13167	usd
	kern	Shares Issued In Connection With Viridian Acquisition SharesIssuedInConnectionWithViridianAcquisition	-940000	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	9178961	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	661423	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	761178	usd
	kern	Stock Issued During Period Value Settlement Of Liabilities StockIssuedDuringPeriodValueSettlementOfLiabilities	49530	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	50000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4505	usd
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	290000	usd
	us-gaap	Profit Loss ProfitLoss	-53822928	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	20094685	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1413942	usd
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	103707	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	300000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	510132	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1828119	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue		usd
CY2021Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	63905	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	-3000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1553447	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	64418307	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	57222621	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	11610587	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	437554	usd
	kern	Shares Issued In Connection With Viridian Acquisition SharesIssuedInConnectionWithViridianAcquisition	6002000	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	300000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1584755	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1828116	usd
	kern	Stock Issued During Period Value Settlement Of Liabilities StockIssuedDuringPeriodValueSettlementOfLiabilities	377325	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	65858	usd
	us-gaap	Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent	-19000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	64418307	usd
	us-gaap	Profit Loss ProfitLoss	-53822928	usd
	us-gaap	Profit Loss ProfitLoss	-14116401	usd
	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	7564	usd
	kern	Fair Value Adjustment Of Contingent Consideration FairValueAdjustmentOfContingentConsideration		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	271474	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	254029	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	697377	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	39600587	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1584751	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	1045179	usd
	kern	Gainon Ppp Loan Forgiveness GainonPPPLoanForgiveness		usd
	kern	Gainon Ppp Loan Forgiveness GainonPPPLoanForgiveness	2234730	usd
	kern	Amortization Of Deferred Contract Costs AmortizationOfDeferredContractCosts	275949	usd
	kern	Amortization Of Deferred Contract Costs AmortizationOfDeferredContractCosts	356528	usd
	kern	Non Cash Interest Expense Non-cashInterestExpense	183723	usd
	kern	Non Cash Interest Expense Non-cashInterestExpense	1161393	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6094963	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3605435	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4718	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-21496	usd
	kern	Gains Losses On Convertible Notes GainsLossesOnConvertibleNotes	-2840000	usd
	kern	Gains Losses On Convertible Notes GainsLossesOnConvertibleNotes	-2030904	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	54153	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	313176	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-462482	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	215228	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-66246	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1356709	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1756671	usd
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-243838	usd
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1413665	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-927916	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10450906	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5077544	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3324029	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3354453	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	27383	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	11535	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-400000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2951412	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3365988	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13167	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	437554	usd
	kern	Proceeds From Unitand Pre Funded Unit Offering Net ProceedsFromUnitandPreFundedUnitOfferingNet	9178960	usd
	kern	Proceeds From Unitand Pre Funded Unit Offering Net ProceedsFromUnitandPreFundedUnitOfferingNet		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	kern	Principal Payments Of Convertible Notes PrincipalPaymentsOfConvertibleNotes	-1432273	usd
	kern	Principal Payments Of Convertible Notes PrincipalPaymentsOfConvertibleNotes	-1164706	usd
	kern	Proceeds From At The Market Offering Program Net ProceedsFromAtTheMarketOfferingProgramNet	761178	usd
	kern	Proceeds From At The Market Offering Program Net ProceedsFromAtTheMarketOfferingProgramNet	1828116	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8494699	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	225856	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-35984	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5915	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4943603	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8223591	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14442526	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18340640	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3925500	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9498923	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10117049	usd
	us-gaap	Interest Paid Net InterestPaidNet	234227	usd
	us-gaap	Interest Paid Net InterestPaidNet	105882	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12200	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10570	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	10448932	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	138419	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	17452497	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	49530	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	377315	usd
	kern	Stock Based Compensation Capitalized As Software Development StockBasedCompensationCapitalizedAsSoftwareDevelopment	14046	usd
	kern	Stock Based Compensation Capitalized As Software Development StockBasedCompensationCapitalizedAsSoftwareDevelopment		usd
	kern	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits	50000	usd
	kern	Vesting Of Restricted Stock Units VestingOfRestrictedStockUnits		usd
	kern	Capitalized Software Included In Accrued Expenses CapitalizedSoftwareIncludedInAccruedExpenses	32473	usd
	kern	Capitalized Software Included In Accrued Expenses CapitalizedSoftwareIncludedInAccruedExpenses		usd
	kern	Shares Returned In Connection With365 Cannabis Acquisition SharesReturnedInConnectionWith365CannabisAcquisition	940000	usd
	kern	Shares Returned In Connection With365 Cannabis Acquisition SharesReturnedInConnectionWith365CannabisAcquisition		usd
	kern	Cannabis Working Capital Funds Released From Accrued Expenses CannabisWorkingCapitalFundsReleasedFromAccruedExpenses	160000	usd
	kern	Cannabis Working Capital Funds Released From Accrued Expenses CannabisWorkingCapitalFundsReleasedFromAccruedExpenses		usd
	us-gaap	Nature Of Operations NatureOfOperations	<div style="border-left: none; border-right: none;"> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business</span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span>Akerna Corp., herein referred to as we, us, our, the Company or Akerna, through our wholly-owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, solo sciences, inc., or Solo, Viridian Sciences Inc., or Viridian, and The NAV People, Inc. d.b.a. 365 Cannabis, or 365 Cannabis, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses’ compliance with state regulations and to help state-licensed businesses operate in compliance with such law. We provide our commercial software platform, MJ Platform®, Trellis®, Ample, Viridian and 365 Cannabis to state-licensed businesses, and our regulatory software platform, Leaf Data Systems®, to state government regulatory agencies. Through Solo, we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with soloTAG™. The integration of MJ Platform® and soloCODE™ results in technology for consumers and brands that brings a consumer-facing mark designed to highlight the authenticity and signify transparency. </span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'times new roman', times; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;"><span>Our Viridian and 365 Cannabis offerings are considered enterprise offerings while all other solutions are considered non-enterprise offerings that meet the needs of our small and medium-sized business, or SMB, customers. </span><br/></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 33.3333pt; line-height: 1.3;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating or expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our advisory engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness, and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets that are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations. </p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 12pt; text-align: justify; line-height: 13pt; margin: 0cm 0cm 0.0001pt;"><b><i><span style="font-size: 10pt; color: #000000;">Going Concern and Management<span style="color: rgb(0, 0, 0); font-family: "times new roman", times; font-size: 13.3333px; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.44px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">’</span>s Liquidity Plans</span></i></b></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; text-align: justify; text-indent: 33.33pt; margin: 0pt 0pt 0.0001pt; line-height: 1.3;"><span style="font-size: 10pt; line-height: inherit;"><span>In accordance with the Financial Accounting Standards Board’s (“FASB”) standard on going concern, Accounting Standard Update (<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">“</span>ASU<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">”</span>) No. 2014-15, <span style="font-style: italic; line-height: inherit;">Disclosure of Uncertainties about an Entity<span style="color: rgb(0, 0, 0); font-family: "times new roman", times; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.44px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">’</span>s Ability to Continue as a Going Concern</span> (<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">“</span>ASU 2014-15<span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">”</span>), we assess going concern uncertainty in our consolidated financial statements to determine if we have sufficient cash, cash equivalents and working capital on hand, including marketable equity securities, and any available borrowings on loans, to operate for a period of at least one year from the date the consolidated financial statements are issued, which is defined to as the “look-forward period” in ASU 2014-15. As part of this assessment, based on conditions that are known and reasonably knowable to us, we will consider various scenarios, forecasts, projections, estimates and will make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, we make certain assumptions regarding implementing curtailments or delays in the nature and timing of programs and expenditures to the extent we deem probable that such implementations can be achieved and we have the proper authority to execute them within the look-forward period in accordance with ASU 2014-15.<br/></span></span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="font-family: 'Times New Roman', serif; font-size: 10pt; text-align: justify; text-indent: 33.33pt; margin: 0pt 0pt 0.0001pt; line-height: 1.3;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important; background-color: #ffffff;"><span><span>The accompanying condensed consolidated financial statements have been prepared on the basis that we will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business. However, since our inception we have experienced recurring losses from operations, used cash from operating activities, and relied on capital raising transactions to continue ongoing operations. During the nine months ended September 30, 2022 and September 30, 2021, we incurred losses from operations of $11.1 million, excluding impairments, and $13.3 million, respectively, and used cash in operating activities of $10.5 million and $</span>5.1<span> million, respectively. As of September 30, 2022, we had a working capital deficit of $6.8 million with $</span>2.5</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;"><span><span style="line-height: inherit;"><span style="background-color: #ffffff; line-height: inherit;"> million in cash available to fund future operations.</span> </span></span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; background-color: #ffffff; display: inline !important; line-height: inherit;"><span><span>Furthermore, on May 24, 2022, we received a notice (the “Notice”) from The Nasdaq Stock Market LLC indicating that the bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market (the “Nasdaq Market”). The Notice has no immediate effect on the continued listing status of our Common Stock on the Nasdaq Market, and, therefore, our listing remains fully effective. We are provided a compliance period of 180 calendar days from the date of the Notice, or until November 21, 2022, to regain compliance with the minimum closing bid requirement. On November 8, 2022, we completed a reverse stock split of 20-for-1 (the “Reverse Stock Split”) to address our bid price compliance and believe that we will regain compliance with the bid price requirement by November 21, 2022. Collectively, these factors raise substantial doubt regarding the ability of the Company to continue as a going concern. </span></span></span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <div style="font-family: 'times new roman', times; font-size: 10pt;"> </div> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.3; font-size: 10pt;"><span><span style="font-size: 13.3333px; line-height: inherit;"> </span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;">Management’s <span>plan for the Company to continue as a going concern includes <span style="font-size: 10pt; line-height: inherit; font-family: 'times new roman', times;">several initiatives and actions including those impacting <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.44px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">continuing costs, primarily labor and technology, including hosting and applications, working capital, our </span>short and intermediate term financing and the liquidity of our Common Stock. Certain of these initiatives and actions began during the second quarter of 2022 while others were initiated thereafter and through the second week of November 2022. </span></span></span></span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.3; font-size: 10pt;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"><span> <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">The most significant components of our plan include the following: </span><span style="border-left: none; border-right: none; line-height: inherit;"><span>(i) realizing annualized cost savings associated with the corporate restructuring initiative (the “Restructuring”) that we announced in May 2022 which resulted in a reduction in workforce and related operating costs (see Note 4), (ii) entering into an amendment and waiver agreement to the securities purchase agreement <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.44px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(the “SPA”) </span>associated with our 2021 Senior Convertible Notes (the “Senior Convertible Notes”) on June 30, 2022 (the “Convertible Notes Amendment”) which, among other factors, provides for the deferral of the required amortization payments due and payable from July 1, 2022 through January 1, 2023 (see Note 6), (iii) securing a waiver from the holders of the Senior Convertible Notes on September 27, 2022 to maintain a reserve of authorized shares equivalent to 200 percent of the total number shares required to satisfy the obligations under the Senior Convertible Notes (the “Required Reserve Amount”), effectively <span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">continuing a similar waiver provided by the holders on June 30, 2022, </span>for a period retroactive to August 30, 2022 through November 30, 2022, (iv) deployment for working capital needs of the net proceeds of approximately $2.0 million received from our offering of Common Stock and warrants (the “2022 Unit Offering”) in a transaction that closed on July 5, 2022 (see Note 10), net of underwriting discounts and commissions and other offering expenses and after depositing $7.0 million of the proceeds into certain restricted cash accounts in accordance with the Convertible Notes Amendment, (v) opportunistic utilization of our “at the market” offering program (the “ATM Program”) for short-term liquidity needs (see Note 10), <span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(vi) addressing the potential liquidity of our Common Stock and increasing the viability of our ATM Program in connection with the minimum listing requirements for the Nasdaq Market through </span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">the Reverse Stock Split that was approved by our shareholders on November 7, 2022 and effectuated at 12:01 a.m Eastern Standard Time on November 8, 2022 (see Note 10), <span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(vii) conservatively managing our working capital through disciplined cost-containment efforts and strategic<span style="line-height: inherit;"> </span></span>management<span style="line-height: inherit;"> </span>of our accounts receivable and accounts payable cycles, (viii) considering strategic partnerships and evaluating potential strategic transactions, as opportunities become available and (ix) </span></span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> continuing to seek to expand our customer base and realize synergies as we continue to integrate our recent acquisitions with a focus on our core business units</span>.</span></span></span></span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.3; font-size: 10pt;"><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">We anticipate that the initiatives and actions associated with our plan described above will provide us with sufficient liquidity in order to operate our business in the normal course for the remainder of 2022 due primarily to the fact that the debt service obligations associated with the Senior Convertible Notes have been deferred to the first half of 2023 and have effectively been substantially pre-funded with the amounts deposited into restricted accounts as required by the Convertible Notes Amendment. In the remainder of 2022, we plan to continue to rigorously explore potential financing alternatives and other strategic options. In addition to and to the extent practical in the future, based on market conditions, we will consider incremental offerings through the ATM Program. From September 30, 2022 through November 10, 2022, we have utilized $0.9 million of the total $3.5 million authorized by the ATM Program. The earn-out payment associated with a 2021 acquisition, which is intended to be made in shares of Common Stock, is scheduled to be settled by the end of December 2022 (see Note 3). If the seller elects for the settlement to be made in cash, it becomes subject to a reduction of 25 percent and could be deferred into the first quarter of 2023.</span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.3; font-size: 10pt;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 10pt; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"><span> If we are unable to <span>secure other potential financing alternatives or fail to execute any other strategic options to raise sufficient additional funds through the first half of 2023, including through the ATM Program, </span> we will have to develop and implement more aggressive plans to <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">address our liquidity needs and our ability to satisfy the scheduled maturity of our obligations under the Senior Convertible Notes.</span> Such plans could include extending payables, further reductions of expenditures (including the termination of additional employees) and reducing or eliminating investments in and the funding of certain of our business units and initiatives, or otherwise substantially scale back our business plan until sufficient additional capital is raised through other equity or debt offerings. <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Such offerings may include the issuance of shares of Common Stock, warrants to purchase Common Stock, preferred stock, convertible debt or other instruments that may dilute the interests of our current shareholders.</span> Accordingly, we may be subject to additional risks, including retention of key employees and limitations on the extension of credit by our vendors and other service providers. </span></span><span>If we are required to raise additional capital as discussed above and if we cannot timely raise additional funds, we may be unable to meet the financial covenants of the Senior Convertible Notes, which could result in an event of default under those instruments which could adversely impact the Company. See the risks detailed in our Form 10-K under “Item 1A. Risk Factors – Risks Relating to our Convertible Debt”.</span></span><br/></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p class="ng-scope" style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.3; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Our ability to continue as a going concern is dependent upon our ability to successfully execute the plans described above and attain profitable operations. <span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif;">Despite the comprehensive scope of our plans, the inherent risks associated with their successful execution are not sufficient to fully overcome </span></span><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">substantial doubt about our ability to continue as a going concern for </span>one<span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> year from the date of issuance of the consolidated financial statements. Accordingly, if we are unable to raise sufficient capital we may have to reduce operations which could significantly and adversely affect our results of operations. If we fail to meet the financial covenants of the Senior Convertible Notes and cannot obtain a waiver from such provisions or otherwise come to an agreement with the holders of our debt, such holders may declare a default on the debt which could subject our assets to seizure and sale, negatively impacting our business. </span></p> <p style="margin: 0pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p class="ng-scope" style="text-indent: 33.33pt; text-align: justify; margin: 0pt 0pt 0.0001pt; line-height: 1.3; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary if the Company is unable to continue as a going concern. </span></p> </div>
	kern	Loss From Operations LossFromOperations	11100000	usd
	kern	Loss From Operations LossFromOperations	13300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	10500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5100000	usd
CY2022Q3	kern	Working Capital WorkingCapital	6800000	usd
CY2022Q3	us-gaap	Cash Cash	2500000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	kern	Bid Price Per Share BidPricePerShare	1
	us-gaap	Substantial Doubt About Going Concern Conditions Or Events SubstantialDoubtAboutGoingConcernConditionsOrEvents	<span>(i) realizing annualized cost savings associated with the corporate restructuring initiative (the “Restructuring”) that we announced in May 2022 which resulted in a reduction in workforce and related operating costs (see Note 4), (ii) entering into an amendment and waiver agreement to the securities purchase agreement <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.44px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(the “SPA”) </span>associated with our 2021 Senior Convertible Notes (the “Senior Convertible Notes”) on June 30, 2022 (the “Convertible Notes Amendment”) which, among other factors, provides for the deferral of the required amortization payments due and payable from July 1, 2022 through January 1, 2023 (see Note 6), (iii) securing a waiver from the holders of the Senior Convertible Notes on September 27, 2022 to maintain a reserve of authorized shares equivalent to 200 percent of the total number shares required to satisfy the obligations under the Senior Convertible Notes (the “Required Reserve Amount”), effectively <span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">continuing a similar waiver provided by the holders on June 30, 2022, </span>for a period retroactive to August 30, 2022 through November 30, 2022, (iv) deployment for working capital needs of the net proceeds of approximately $2.0 million received from our offering of Common Stock and warrants (the “2022 Unit Offering”) in a transaction that closed on July 5, 2022 (see Note 10), net of underwriting discounts and commissions and other offering expenses and after depositing $7.0 million of the proceeds into certain restricted cash accounts in accordance with the Convertible Notes Amendment, (v) opportunistic utilization of our “at the market” offering program (the “ATM Program”) for short-term liquidity needs (see Note 10), <span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(vi) addressing the potential liquidity of our Common Stock and increasing the viability of our ATM Program in connection with the minimum listing requirements for the Nasdaq Market through </span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">the Reverse Stock Split that was approved by our shareholders on November 7, 2022 and effectuated at 12:01 a.m Eastern Standard Time on November 8, 2022 (see Note 10), <span style="color: #000000; font-family: 'Times New Roman', serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 44.4444px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(vii) conservatively managing our working capital through disciplined cost-containment efforts and strategic<span style="line-height: inherit;"> </span></span>management<span style="line-height: inherit;"> </span>of our accounts receivable and accounts payable cycles, (viii) considering strategic partnerships and evaluating potential strategic transactions, as opportunities become available and (ix) </span></span><span style="font-size: 10pt; font-family: 'Times New Roman', serif; border-left: none; border-right: none; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> continuing to seek to expand our customer base and realize synergies as we continue to integrate our recent acquisitions with a focus on our core business units</span>.
	kern	Description Of Liquidity And Capital Resources DescriptionOfLiquidityAndCapitalResources	We anticipate that the initiatives and actions associated with our plan described above will provide us with sufficient liquidity in order to operate our business in the normal course for the remainder of 2022 due primarily to the fact that the debt service obligations associated with the Senior Convertible Notes have been deferred to the first half of 2023 and have effectively been substantially pre-funded with the amounts deposited into restricted accounts as required by the Convertible Notes Amendment. In the remainder of 2022, we plan to continue to rigorously explore potential financing alternatives and other strategic options. In addition to and to the extent practical in the future, based on market conditions, we will consider incremental offerings through the ATM Program. From September 30, 2022 through November 10, 2022, we have utilized $0.9 million of the total $3.5 million authorized by the ATM Program. The earn-out payment associated with a 2021 acquisition, which is intended to be made in shares of Common Stock, is scheduled to be settled by the end of December 2022 (see Note 3). If the seller elects for the settlement to be made in cash, it becomes subject to a reduction of 25 percent and could be deferred into the first quarter of 2023.
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4630681	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0cm; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif;"><span style="font-family: 'times new roman', times;"><b><i><span style="font-size: 10.0pt;">Use of Estimates</span></i></b></span></p> <p style="text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; margin: 0px; text-indent: 0px;"><br/></p> <p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the consolidated financial statements and accompanying notes thereto. Our most significant estimates and assumptions are related to the valuation of acquisition-related assets and liabilities, capitalization of internal costs associated with software development, fair value measurements, impairment assessments, loss contingencies, valuation allowance associated with deferred tax assets, stock based compensation expense, and useful lives of long-lived intangible assets. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results could differ from those estimates. </span></span></span></p>
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	900000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	300000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b><i><span style="font-size: 10pt; line-height: inherit;">Concentrations of Credit Risk</span></i></b></span></p> <p style="margin: 0cm; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.3; ;margin: 0px !important;"><br/></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span style="font-size: 10pt; color: #000000; font-family: 'times new roman', times; line-height: inherit;">We grant credit in the normal course of business to customers in the United States and Canada. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk. </span></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; ;margin: 0px !important;"><br/></p> <p style="margin: 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-indent: 33.3333pt; line-height: 1.3; text-align: justify;"><span><span style="font-size: 10pt; color: #000000; line-height: inherit;"><span>During the nine<span style="border-left: none; border-right: none; line-height: inherit;"> months ended September 30, 2022</span> and 2021, <span>two </span>government clients accounted for 12<span>% and 11%</span> of total revenues, respectively. <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">As of <span style="border-right: none; border-left: none; line-height: inherit;">September 30, 2022,</span> </span>two government clients accounted for 46% of net accounts receivable and as of December 31, 2021 two government clients accounted for 36% of net accounts receivable. </span></span></span></p>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	34336	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	37585	usd
CY2022Q3	kern	Offering Sharesof Common Stock OfferingSharesofCommonStock	402345	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3883847	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1322122	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2421262	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1215626	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-22.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.61
CY2022Q2	dei	Entity Number Of Employees EntityNumberOfEmployees	59	employees
CY2022Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated Period Percent RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent	0.33	pure
CY2022Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	600000	usd
CY2022Q2	us-gaap	Marketing Expense MarketingExpense	300000	usd
CY2022Q2	us-gaap	Development Costs DevelopmentCosts	300000	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	100000	usd
	kern	Reduction Of Purchase Price ReductionOfPurchasePrice	25	usd
CY2021Q4	kern	Initially Measured A Fair Value InitiallyMeasuredAFairValue	6.3	usd
	kern	Reduction Of Working Capital ReductionOfWorkingCapital	1500000	usd
CY2022Q2	kern	Commonstockofferingpercentage Commonstockofferingpercentage	0.25	pure
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	6300000	usd
CY2022Q3	kern	Accrued Contractors AccruedContractors	556766	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	22218616000	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	15472157000	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	7520320	usd
CY2022Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1982553	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18450000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	14056000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18450000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	14056000	usd
CY2022Q3	kern	Unsatisfied Performance Obligations UnsatisfiedPerformanceObligations	23000000	usd
	kern	Revenueexpectedtoberecognized Revenueexpectedtoberecognized	12200000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	4126000	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	11793000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	13269000	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	2650000	usd
CY2022Q3	us-gaap	Deferred Income DeferredIncome	18400000	usd
CY2021Q4	us-gaap	Deferred Income DeferredIncome	3800000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	261000	usd
	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	289000	usd
	kern	Amortized Costs AmortizedCosts	-276000	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	274000	usd
CY2022Q3	kern	Weighted To The Income Approach WeightedToTheIncomeApproach	0.50	pure
CY2022Q3	kern	Impairment Expenses ImpairmentExpenses	3200000	usd
CY2021Q4	kern	Accrued Contractors AccruedContractors	1288730	usd
CY2022Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	14475000	usd
CY2021Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	17305000	usd
CY2022Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	9900000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13200000	usd
CY2022Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	4575000	usd
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	4105000	usd
CY2022Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	14500000	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.005	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.0007	pure
	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	80
CY2022Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	100000	usd
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	100000	usd
CY2022Q3	kern	Prepaid Expenses Software And Technology PrepaidExpensesSoftwareAndTechnology	399824	usd
CY2021Q4	kern	Prepaid Expenses Software And Technology PrepaidExpensesSoftwareAndTechnology	687740	usd
CY2022Q3	kern	Prepaid Professional Fees PrepaidProfessionalFees	297106	usd
CY2021Q4	kern	Prepaid Professional Fees PrepaidProfessionalFees	546126	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	215762	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	264097	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	273521	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	260899	usd
CY2022Q3	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	841453	usd
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	506984	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	302366	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	117918	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2330032	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2383764	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1270695	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1943457	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	234750	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	319590	usd
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	515789	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	360361	usd
CY2022Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	517359	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1123467	usd
CY2022Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1084294	usd
CY2021Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	3834001	usd
CY2021Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	681045	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	451028	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	346870	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6063520	usd
	kern	Legalproceedings Legalproceedings	no
	kern	Termination Fee TerminationFee	500000	usd
CY2022Q4	us-gaap	Common Stock Voting Rights CommonStockVotingRights	reverse stock split of the outstanding shares of Common Stock by a ratio of 20 for 1
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1
CY2022Q3	kern	Exchangeable Shares ExchangeableShares	18094	shares
CY2022Q3	kern	Aggregate Value Of Exchangeable Shares AggregateValueOfExchangeableShares	138419	usd
CY2022Q3	kern	Exchangeable Shares Issued ExchangeableSharesIssued	904	shares
CY2022Q3	kern	Exchangeable Shares Outstanding ExchangeableSharesOutstanding	291192	shares
CY2022Q3	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	14560	shares
	kern	Descriptionofunitoffering Descriptionofunitoffering	(i) 29,382,861 units consisting of 1,469,143 shares of Common Stock together with Common Stock warrants (the “Common Warrants”) to purchase up to 1,469,143 shares of Common Stock (together, the “Units”) and (ii) 14,095,400 pre-funded units, consisting of 14,095,400 pre-funded warrants (“Pre-funded Warrants”) to purchase 704,770 shares of Common Stock, together with Common Warrants to purchase up to 704,770 shares of Common Stock (together, the “Pre-funded Units”). The Units were sold at a public offering price of $0.23 per unit and the Pre-funded Units were sold at a public offering price of $0.2299 per pre-funded unit.
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.6
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.518
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.6
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9200000	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	7000000	usd
CY2022Q3	kern	Warrants Outstanding WarrantsOutstanding	45652174	shares
CY2022Q3	kern	Common Warrants Shares CommonWarrantsShares	43478261	shares
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9200000	usd
	kern	Underwriting Agreement Description UnderwritingAgreementDescription	(i) an increase to Common Stock of $217 representing the issuance of 1,469,143 shares of Common Stock attributable to the Units and the issuance of 704,770 shares of Common Stock from the exercise of the Pre-funded Warrants<span>, both at their par value of $0.0001 per share </span>and (ii) an increase to Additional Paid-In Capital of $9.2 million for the amounts received over par value less the underwriting discounts and commissions and related expenses <span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">including legal and other professional fees</span>.
	kern	Equity Instrument Convertible Conversion Ratio EquityInstrumentConvertibleConversionRatio	1	pure
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5813800	shares
CY2022Q3	kern	Warrants Issued In Period Number Of Shares WarrantsIssuedInPeriodNumberOfShares	59747574	shares
	kern	Warrants Exercised In Period Weighted Average Grant Date Fair Value WarrantsExercisedInPeriodWeightedAverageGrantDateFairValue	-14095400
	kern	Warrants Forfeited In Period Weighted Average Grant Date Fair Value WarrantsForfeitedInPeriodWeightedAverageGrantDateFairValue
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	51465974	shares
CY2022Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	13388000	usd
CY2021Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	6152000	usd
CY2022Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2021Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2344226	usd
CY2022Q3	kern	Changes In Fair Value Reported In Statements Of Operations ChangesInFairValueReportedInStatementsOfOperations	1113000	usd
CY2021Q3	kern	Changes In Fair Value Reported In Statements Of Operations ChangesInFairValueReportedInStatementsOfOperations	23227	usd
CY2022Q3	kern	Change In Fair Value Reported In Other Comprehensive Income ChangeInFairValueReportedInOtherComprehensiveIncome	-26000	usd
CY2021Q3	kern	Change In Fair Value Reported In Other Comprehensive Income ChangeInFairValueReportedInOtherComprehensiveIncome	3000	usd
CY2022Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	14475000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	11613903	usd
CY2021Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	17305000	usd
CY2020Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	13398000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	5380000	usd
	kern	Changes In Fair Value Reported In Statements Of Operations ChangesInFairValueReportedInStatementsOfOperations	2840000	usd
	kern	Changes In Fair Value Reported In Statements Of Operations ChangesInFairValueReportedInStatementsOfOperations	2030904	usd
	kern	Change In Fair Value Reported In Other Comprehensive Income ChangeInFairValueReportedInOtherComprehensiveIncome	-290000	usd
	kern	Change In Fair Value Reported In Other Comprehensive Income ChangeInFairValueReportedInOtherComprehensiveIncome	19000	usd
CY2022Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	14475000	usd
CY2021Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	3834001	usd
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	6.21
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price Increase DebtInstrumentConvertibleConversionPriceIncrease	81
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2602792	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	418521	shares

Files In Submission

Name	View Source	Status
0001213900-22-072131-index-headers.html	Edgar Link	pending
0001213900-22-072131-index.html	Edgar Link	pending
0001213900-22-072131.txt	Edgar Link	pending
0001213900-22-072131-xbrl.zip	Edgar Link	pending
ex102_4.htm	Edgar Link	pending
ex103_5.htm	Edgar Link	pending
ex311_6.htm	Edgar Link	pending
ex312_7.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex321_8.htm	Edgar Link	pending
ex322_9.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
ex41_3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kern-20220930.htm	Edgar Link	pending
kern-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
kern-20220930_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kern-20220930_pre.xml	Edgar Link	unprocessable
kern-20220930_def.xml	Edgar Link	unprocessable
kern-20220930_lab.xml	Edgar Link	unprocessable
kern-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GRYP
Gryphon Digital Mining Inc Stock $gryp

2022 Q4 Form 10-Q Financial Statement

#000121390022072131 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRYP Gryphon Digital Mining Inc Stock $gryp

2022 Q4 Form 10-Q Financial Statement

#000121390022072131 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GRYP
Gryphon Digital Mining Inc Stock $gryp